Spectra Group get on their bikes
Last updated: Thursday, 26th April 2012, 14:49 Spectra Group have had a bit of bad news recently in that Major Jim Boyle a close friend of Spectra, has been recently diagnosed with Myeloma.
Spectra Group have had a bit of bad news recently in that Major Jim Boyle a close friend of Spectra, has been recently diagnosed with Myeloma.
We would like to give back, in some small way, a little something to support those people affected by Myeloma to help improve treatment, standards of care through research, and raise awareness.
With this in mind a small team from Spectra will be cycling the Coast to Coast cycle route for Myeloma UK over the period 5th – 9th July 2012.
The route was opened in 1994 running from Whitehaven on the west coast of Cumbria to the North East coast at Sunderland, and has an average of between 12,000 and 15,000 cyclists completing the route every year (and literally hundreds of thousands of other doing shorter sections). At 147 miles long, the C2C is part of the much larger National Cycle Network of nearly 10,000 miles. It is Britain’s most popular long distance cycle route and is based on minor roads, disused railway lines, off-road tracks and specially constructed cycle paths.
If you can help hit our target of £5000 we would be very grateful.
What we would like you do to do is visit our JustGiving Page at this link : http://www.justgiving.com/spectra-group and drop of a few of your well-earned pounds to the Myeloma UK charity, who are now very active in helping Jim during this difficult time for him and his family.
Finally anyone knows Jim will know that he is a top man and absolutely a fighter. We all wish him the best with his treatment and recovery from the illness.
Myeloma is an increasingly common cancer of plasma cells. Plasma cells are found in the bone marrow and are responsible for protecting the body against infection. In myeloma, a single defective plasma cell (a myeloma cell) multiples rapidly, displacing the healthy bone marrow.
• There are approximately 4,000 new cases of myeloma every year in the UK
• It is the second most common form of bone marrow cancer and represents 1% of all cancers
• 97% of people in a recent survey did not know what it was.
Improvement in treatments has meant that survival rates in myeloma are increasing at the fastest rate among all cancer types in the UK.
Charity Registration No. SC026116
Registered as a charity in 1997, Myeloma UK is the only organisation in the UK dealing exclusively with myeloma and its related disorders.
Our broad and innovative range of services cover every aspect of myeloma, from information and support to improving standards of treatment and care through education, research, campaigning and raising awareness.